Ninety One (UK)
RDY icon

Ninety One (UK)’s Dr. Reddy's Laboratories RDY Stock Holding History

Ninety One (UK)’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-105,880
Closed -$1.11M – 198
2022
Q3 		$1.11M Buy
105,880
+6,835
+7% +$72.8K ﹤0.01% 177
2022
Q2 		$1.1M Buy
99,045
+2,015
+2% +$21.9K ﹤0.01% 180
2022
Q1 		$1.08M Sell
97,030
-5,995
-6% -$68K ﹤0.01% 187
2021
Q4 		$1.35M Buy
103,025
+15,585
+18% +$196K ﹤0.01% 196
2021
Q3 		$1.14M Buy
87,440
+2,260
+3% +$30.1K ﹤0.01% 196
2021
Q2 		$1.25M Buy
85,180
+2,020
+2% +$28.2K ﹤0.01% 200
2021
Q1 		$1.02M Hold
83,160
– – ﹤0.01% 207
2020
Q4 		$1.19M Sell
83,160
-787,325
-90% -$10.6M ﹤0.01% 207
2020
Q3 		$12.1M Buy
870,485
+66,380
+8% +$791K 0.04% 168
2020
Q2 		$8.53M Buy
804,105
+476,590
+146% +$4.85M 0.03% 174
2020
Q1 		$2.64M Buy
+327,515
New +$2.73M 0.01% 208
2014
Q2 		– Sell
-2,517,500
Closed -$22.1M – 259
2014
Q1 		$22.1M Buy
+2,517,500
New +$21.9M 0.15% 137

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Ninety One (UK)'s RDY Position: Q4 2022 in Review

Ninety One (UK) sold out of Dr. Reddy's Laboratories (RDY) in Q4 2022, closing a stake of 105,880 shares — an estimated $1.11M sold.

Ninety One (UK) first reported a position in RDY in Q1 2014 and held it in 12 quarters. The position peaked at $22.1M in Q1 2014. 161 funds tracked by Wall St. Rank hold RDY as of Q4 2022.

  • Ninety One (UK) reported no remaining Dr. Reddy's Laboratories position as of Q4 2022 after selling out during the quarter.
  • Ninety One (UK) sold 105,880 Dr. Reddy's Laboratories shares in Q4 2022, an estimated $1.11M.
  • Ninety One (UK) first reported a position in Dr. Reddy's Laboratories in Q1 2014 and held it in 12 quarters.
  • Ninety One (UK)'s Dr. Reddy's Laboratories position peaked at $22.1M in Q1 2014.
  • 161 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2022.

Based on Ninety One (UK)'s 13F filing for Q4 2022, filed 7 Feb 2023.